Clinical Trial Update: Antibody Response to COVID-19 Vaccines in Liver Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating antibody response to COVID-19 vaccines in patients with chronic liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Snippet

Sponsor: Humanity & Health Medical Group Limited | Conditions: Chronic Liver Disease | Phase 4 | Status: COMPLETED